Create Account
Sign In
Dark
chart
exchange
Terminal
Screener
Stocks
Crypto
Forex
Watchlists
Trends

BXRX
Baudax Bio Inc
stock NASDAQ

At Close
3/24/2023 3:59:30 PM EDT
1.55USD-0.641%(-0.01)92,572
1.24Bid   1.58Ask   0.34Spread IEX
Pre-market
3/24/2023 9:15:30 AM EDT
1.52USD-2.564%(-0.04)100
After-hours
3/20/2023 4:01:30 PM EDT
1.60USD0.000%(0.00)0
OverviewHistoricalExchange VolumeShort VolumeBorrow FeeFailure to DeliverTrendsNewsNews
Jan 20, 2022
07:40AM EST  The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.25 A.M. ET).   RTTNews
Jan 4, 2022
07:00AM EST  Baudax Bio, Inc. (NASDAQ:BXRX) a pharmaceutical company focused on commercializing and developing innovative products for acute care settings, today announced that Gerri Henwood, the Companys President and Chief Executive Officer, will present at the H.C. Wainwright BIOCONNECT Virtual Conference being held January 10 - 13, 2022.   GlobeNewswire Inc
Dec 31, 2021
04:05PM EST  Baudax Bio Reports Inducement Grant Under Nasdaq Listing Rule   GlobeNewswire Inc
Dec 28, 2021
02:39PM EST  Mid-Afternoon Market Update: Nasdaq Down 0.5%; Flotek Industries Shares Spike Higher   Benzinga
12:14PM EST  Mid-Day Market Update: Crude Oil Rises 1%; Baudax Bio Shares Plummet   Benzinga
10:03AM EST  Baudax Bio, Inc. (BXRX) shares are sliding more than 24 percent on Tuesday morning trade after the company said it has entered into a definitive agreement with certain institutional investors for the issuance and sale of 42,289.3 shares of convertible preferred stock and warrants to purchase up to an aggregate of 12,686,790 shares of common stock.   RTTNews
08:01AM EST  Baudax Bio Announces $4.2M Registered Direct Offering   Benzinga
08:00AM EST  Baudax Bio Announces $4.2 Million Registered Direct Offering   GlobeNewswire Inc
Dec 16, 2021
09:28AM EST  Baudax Bio Says As Of Dec. 14 Co. Was Not In Compliance With Nasdaq Listing Rule 5550(a)(2)   Benzinga
Nov 15, 2021
07:00AM EST  Baudax Bio, Inc. (NASDAQ:BXRX) a pharmaceutical company focused on commercializing and developing innovative products for acute care settings, today announced Gerri Henwood, the Companys President and Chief Executive Officer, will participate in a fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference being held November 29 December 2, 2021.   GlobeNewswire Inc
Nov 11, 2021
07:09AM EST  Baudax Bio Announces BX-1000 Completes Dose-Escalation Study; Was Generally Well Tolerated And 'Rapidly Achieved Muscle Paralysis, Along With Complete Spontaneous Recovery'   Benzinga
07:00AM EST  BX-1000 Completes Dose-Escalation Study; Was Generally Well Tolerated and Rapidly Achieved Muscle Paralysis, Along with Complete Spontaneous Recovery   GlobeNewswire Inc
Nov 4, 2021
07:58AM EDT  Baudax Bio Q3 EPS $(0.20) Misses $(0.15) Estimate, Sales $281.00K Miss $600.00K Estimate   Benzinga
07:00AM EDT  ANJESO Revenue Up 40% in Q3 2021 over Q2 2021 and Up Over 300% in Q3 2021 over Q3 2020   GlobeNewswire Inc
05:00AM EDT  Earnings Scheduled For November 4, 2021   Benzinga
Oct 28, 2021
07:00AM EDT  Baudax Bio to Report Third Quarter 2021 Financial Results and Host   GlobeNewswire Inc
06:01AM EDT  The following are some of the stocks making big moves in Thursday's pre-market trading (as of 05.45 A.M. EDT).   RTTNews
Oct 18, 2021
10:21AM EDT  Overview Of Value Stocks In The Healthcare Sector   Benzinga
Oct 11, 2021
10:50AM EDT  5 Value Stocks To Watch In The Healthcare Sector   Benzinga
Oct 5, 2021
07:00AM EDT  Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on commercializing and developing innovative products for acute care settings, today announced that management will give a corporate presentation followed by a question and answer session at the NobleCon Pain Management Investor Forum being held virtually on Thursday, October 7, 2021.   GlobeNewswire Inc
Oct 1, 2021
04:18PM EDT  Baudax Bio Reports Inducement Grant Under Nasdaq Listing Rule   GlobeNewswire Inc
Sep 16, 2021
07:00AM EDT  Baudax Bio to Participate in the Oppenheimer Fall Healthcare Life   GlobeNewswire Inc
Sep 7, 2021
07:00AM EDT  Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on commercializing and developing innovative products for acute care settings, today announced that Gerri Henwood, the Companys President and Chief Executive Officer, will give a corporate presentation at the H.C. Wainwright 23rd Annual Global Investment Conference, being held virtually September 13-15, 2021.   GlobeNewswire Inc
Sep 6, 2021
10:27AM EDT  5 Value Stocks In The Healthcare Sector   Benzinga
Sep 1, 2021
06:07AM EDT  The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 5.45 A.M. EDT).   RTTNews
Aug 24, 2021
05:57AM EDT  The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 5.45 A.M. EDT).   RTTNews
05:41AM EDT  Baudax CFO Richard Casten Richard Reported Purchase of 50,000 Shares @ Avg Price of $0.51/Share in Form 4 Filing on Monday; Baudax Shares +50% Premarket   Benzinga
Aug 23, 2021
10:20AM EDT  5 Value Stocks In The Healthcare Sector   Benzinga
Aug 17, 2021
08:28AM EDT  The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business   Benzinga
Aug 16, 2021
10:31AM EDT  Overview Of Value Stocks In The Healthcare Sector   Benzinga
Aug 13, 2021
07:43AM EDT  The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO   Benzinga
Aug 12, 2021
08:09AM EDT  The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma   Benzinga
Aug 6, 2021
07:42AM EDT  The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO   Benzinga
Aug 5, 2021
08:05AM EDT  Baudax Bio: Q2 Earnings Insights   Benzinga
07:35AM EDT  Baudax Bio Q2 EPS $(0.21) Misses $(0.20) Estimate, Sales $201.00K Miss $470.00K Estimate   Benzinga
07:00AM EDT  Total Number of ANJESO Vials Sold to End-Users in the Second Quarter 2021 Match Total Vials Sold for the Full Year 2020   GlobeNewswire Inc
04:08AM EDT  Earnings Scheduled For August 5, 2021   Benzinga
Jul 30, 2021
04:05PM EDT  Baudax Bio Announces Date of Reconvened Special Meeting   GlobeNewswire Inc
Jul 29, 2021
07:00AM EDT  Baudax Bio to Report Second Quarter 2021 Financial Results and   GlobeNewswire Inc
Jul 20, 2021
08:20AM EDT  The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street   Benzinga
Jul 16, 2021
07:37AM EDT  The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study   Benzinga
Jul 15, 2021
08:08AM EDT  The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs   Benzinga
Jul 9, 2021
07:36AM EDT  The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO   Benzinga
Jul 8, 2021
07:45AM EDT  The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test   Benzinga
Jul 7, 2021
07:41AM EDT  The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend   Benzinga
Jul 1, 2021
07:00AM EDT  Leading Independent Proxy Advisory Firm Glass Lewis & Co.   GlobeNewswire Inc
Jun 30, 2021
07:00AM EDT  Leading Independent Advisory Firm Institutional Shareholder   GlobeNewswire Inc
Jun 18, 2021
04:07PM EDT  Baudax Bio Announces Special Meeting of Shareholders to Vote on Proposed Increase in Number of Authorized Shares of Common Stock   Benzinga
04:05PM EDT  Baudax Bio Announces Special Meeting of Shareholders to Vote on   GlobeNewswire Inc
Jun 10, 2021
07:00AM EDT  Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on developing and commercializing innovative products for acute care settings, today announced Gerri Henwood, the Companys President and Chief Executive Officer, will participate in a fireside chat virtually at the JMP Securities Life Sciences Conference on Thursday, June 17, 2021 at 4:00 p.m. ET.   GlobeNewswire Inc
Jun 8, 2021
07:00AM EDT  Baudax Bios ANJESO Achieves   GlobeNewswire Inc
May 28, 2021
04:06PM EDT  Baudax Bio Reports Cancellation Of Adjourned Portion Of Annual Shareholder Meeting   Benzinga
04:05PM EDT  Baudax Bio Announces the Cancellation of Adjourned Portion of   GlobeNewswire Inc
May 27, 2021
07:00AM EDT  Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on developing and commercializing innovative products for acute care settings, today announced Gerri Henwood, the Companys President and Chief Executive Officer, will present at the 2021 Jefferies Virtual Healthcare Conference on Friday, June 4, 2021 at 2:00 p.m. ET.   GlobeNewswire Inc
May 17, 2021
07:05AM EDT  Baudax Bio Highlights Publication Of Phase IIIb ANJESO Data In Pain Management Journal   Benzinga
07:00AM EDT  Baudax Bio Announces Publication of Phase IIIb ANJESO   GlobeNewswire Inc
May 13, 2021
07:00AM EDT  Leading Independent Advisory Firm Institutional Shareholder   GlobeNewswire Inc
May 12, 2021
09:05AM EDT  Baudax Bio Reports Glass Lewis Recommended Shareholders Vote For Proposal 3   Benzinga
09:03AM EDT  Leading Independent Proxy Advisory Firm Glass Lewis & Co.   GlobeNewswire Inc
08:57AM EDT  The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron   Benzinga
May 11, 2021
04:05PM EDT  Baudax Bio Announces Partial Adjournment of Annual Meeting of   GlobeNewswire Inc
May 7, 2021
07:40AM EDT  The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs   Benzinga
May 6, 2021
07:49AM EDT  The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom   Benzinga
May 5, 2021
08:03AM EDT  Recap: Baudax Bio Q1 Earnings   Benzinga
07:22AM EDT  Baudax Bio Q1 EPS $(0.27) Misses $(0.19) Estimate   Benzinga
07:00AM EDT  ANJESO Demonstrates Continued Progress with Launch; Growth in End-User Unit Sales Increased 40% in Q1 compared to Q420   GlobeNewswire Inc
04:16AM EDT  Earnings Scheduled For May 5, 2021   Benzinga
Apr 29, 2021
07:00AM EDT  Baudax Bio to Report First Quarter 2021 Financial Results and Host   GlobeNewswire Inc
Apr 26, 2021
10:05AM EDT  Baudax Bio's Preoperative Med Associated With Pain Reduction, Lower Opioids Use In Patients After Knee Replacement   Benzinga
07:06AM EDT  Baudax Bio Highlights Publication Of Phase IIIb Data On Preoperative Administration Of ANJESO In Patients Undergoing Total Knee Arthroplasty (TKA) in Pain Medicine   Benzinga
07:00AM EDT  Patients Administered ANJESO Prior to the Start of Surgery had Significantly Lower Summed Pain Intensity Scores on the First Postsurgical Day and Throughout Their Inpatient Course   GlobeNewswire Inc
Apr 8, 2021
04:05PM EDT  Baudax Bio Announces Partial Adjournment of Annual Meeting of   GlobeNewswire Inc
Apr 1, 2021
07:00AM EDT  Baudax Bio Reports Inducement Grant Under Nasdaq Listing Rule   GlobeNewswire Inc
Mar 10, 2021
07:00AM EST  Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that Gerri Henwood, President and Chief Executive Officer, will participate in a fireside chat at the virtual Oppenheimer 31st Annual Healthcare Conference on Thursday, March 18, 2021 at 9:20 a.m. ET.   GlobeNewswire Inc
Mar 8, 2021
07:07AM EST  Baudax Bio Announces Richard Casten CFO   Benzinga
07:00AM EST  Baudax Bio Strengthens Management Team with Appointment of Richard   GlobeNewswire Inc
Mar 2, 2021
07:00AM EST  Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that Gerri Henwood, President and Chief Executive Officer, will give a corporate presentation at the H.C. Wainwright Global Life Sciences Conference, being held virtually March 9-10, 2021.   GlobeNewswire Inc
Feb 16, 2021
08:36AM EST  Baudax Bio: Q4 Earnings Insights   Benzinga
07:10AM EST  Baudax Bio Reports FY2020 EPS $(3.93) Vs $(3.48) YoY   Benzinga
07:00AM EST  Deepening Usage of ANJESO Evidenced by a Reorder Rate of 60% by the End of 2020 and 58% Growth in Vials Sold from the Sequential Quarter   GlobeNewswire Inc
06:49AM EST  Earnings Scheduled For February 16, 2021   Benzinga
Feb 10, 2021
08:05AM EST  Baudax Bio to Report 2020 Annual Financial Results and Host   GlobeNewswire Inc
Feb 8, 2021
03:25PM EST  Baudax Bio Prices 11M Share Offering At $1.60/Share   Benzinga
03:25PM EST  Baudax Bio Announces $17.6 Million Offering Priced At-the-Market   GlobeNewswire Inc
Jan 21, 2021
09:57AM EST  Baudax Bio Reports Exercise Of Warrants For Gross Proceeds Of $13.4 Mln   RTTNews
09:29AM EST  Baudax Bio Announces Exercise of Warrants for Gross Proceeds of   GlobeNewswire Inc
Jan 6, 2021
07:00AM EST  Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that Gerri Henwood, the Companys President and Chief Executive Officer, will present a corporate overview at the H.C. Wainwright BioConnect 2021 Conference, being held virtually January 11-14, 2021.   GlobeNewswire Inc
Dec 17, 2020
07:07AM EST  Baudax Bio Prices 10.3M Common Stock, Warrants Offering At $1.165/Share   Benzinga
07:00AM EST  Baudax Bio Announces $12 Million Offering Priced at a Premium to   GlobeNewswire Inc
Nov 30, 2020
04:05PM EST  Baudax Bio to Participate in the Piper Sandler 32nd Annual   GlobeNewswire Inc
Nov 23, 2020
08:12AM EST  Baudax Bio Announces $12M Offering Of 10,126,583 Shares Priced At $1.185/Share   Benzinga
08:00AM EST  Baudax Bio Announces $12 Million Offering Priced at a Premium to   GlobeNewswire Inc
Nov 20, 2020
07:04AM EST  Baudax Bio Announces Publication of ANJESO Network Meta-Analysis in the Peer-Reviewed Journal BMC Anesthesiology   Benzinga
07:00AM EST  Baudax Bio Announces Publication of ANJESO Network   GlobeNewswire Inc
Nov 19, 2020
07:00AM EST  Baudax Bio Announces an additional Orange Book listed patent for   GlobeNewswire Inc
Nov 11, 2020
07:38AM EST  The Daily Biotech Pulse: Five Prime Skyrockets, Multiple Conference Presentations On Tap   Benzinga
Nov 9, 2020
07:36AM EST  Baudax Bio Q3 EPS $0.62 Beats $(0.74) Estimate, Sales $68.00K Miss $1.00M Estimate   Benzinga
07:05AM EST  ANJESO Launch Underway; Over 50 Institutions have Added ANJESO to Their Formularies with Users Giving Highly Positive Feedback and Average Monthly Orders Increasing over 125% Since Launch   GlobeNewswire Inc
04:13AM EST  Earnings Scheduled For November 9, 2020   Benzinga
Nov 2, 2020
07:05AM EST  Baudax Bio to Report Third Quarter 2020 Financial Results and Host   GlobeNewswire Inc
Oct 30, 2020
10:34AM EDT  Baudax Bio 13G Filing From Sabby Shows Raised Stake To ~1.04M Shares, Or 5.32% Stake   Benzinga
08:09AM EDT  The Daily Biotech Pulse: Novavax Vaccine Data, Axovant Flags Delay In Parkinson's Study, 2 Biotechs Make Wall Street Debuts   Benzinga
Oct 29, 2020
07:30AM EDT  The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal   Benzinga
Oct 27, 2020
08:25AM EDT  The Daily Biotech Pulse: Catabasis Halts Duchenne Muscular Dystrophy Study, Lilly's COVID-19 Trial Disappointment, Merck, Pfizer Earnings   Benzinga
Oct 26, 2020
08:29AM EDT  Stocks Trading Near 52-Week Lows Before Open On Monday, Oct. 26, 2020: HYLN, BSGM, BXRX   Benzinga
Oct 22, 2020
07:52AM EDT  The Daily Biotech Pulse: FDA Vaccine Committee Meeting, Roche In $350M Deal for COVID-19 Treatment, Edwards Lifesciences Reports Q3 Beat   Benzinga
Oct 21, 2020
09:37AM EDT  Stocks Trading Near 52-Week Lows In The Pre-Market Session On Wednesday, Oct. 21, 2020: JAGX, HYLN, BUR, ICPT, DCRBU, BXRX, IH, RDI, RBAC   Benzinga
08:04AM EDT  The Daily Biotech Pulse: Prothena Progress In Parkinson's Disease Pipeline, Fast Track For Xeris, Biogen Earnings   Benzinga
Oct 20, 2020
02:34PM EDT  Mid-Afternoon Market Update: Dow Rises 1%; Aptinyx Shares Spike Higher   Benzinga
12:12PM EDT  Mid-Day Market Update: Cleveland BioLabs Jumps On Merger News; Isoray Shares Slide   Benzinga
07:00AM EDT  ANJESO Launch Underway; Over 50 Institutions have Added ANJESO to Their Formularies   GlobeNewswire Inc
Oct 2, 2020
04:05PM EDT  Baudax Bio Reports Inducement Grants Under Nasdaq Listing Rule   GlobeNewswire Inc
Sep 18, 2020
07:35AM EDT  Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced Gerri Henwood, the Companys President and Chief Executive Officer, will present at the Oppenheimer Fall Healthcare Life Sciences & Medtech Summit on Tuesday, September 22, 2020 at 3:20 p.m. ET.   GlobeNewswire Inc
Aug 25, 2020
04:14PM EDT  Baudax Bio Awarded Group Purchasing Agreement with Premier Inc. for ANJESO; The New Agreement Allows Premier Members, At Their Discretion, To Take Advantage Of Special Pricing And Terms Pre-negotiated By Premier For Anjeso (Meloxicam) Injection   Benzinga
04:05PM EDT  Baudax Bio Awarded Group Purchasing Agreement with Premier Inc.   GlobeNewswire Inc
Aug 20, 2020
05:58PM EDT  Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that Arnold Baskies, M.D. and Andrew Drechsler, have been appointed to the Company's Board of Directors.   GlobeNewswire Inc
Aug 10, 2020
07:29AM EDT  Baudax Bio Q2 EPS $(1.72) Down From $(1.13) YoY, Sales $349.00K   Benzinga
07:15AM EDT  Baudax Bio Reports Second Quarter 2020 Financial Results   GlobeNewswire Inc
Aug 6, 2020
09:12AM EDT  Baudax Bio Earlier Announced Securing Of Permanent J-Code (J1738) For ANJESO From Centers For Medicare And Medicaid Services   Benzinga
07:00AM EDT  Baudax Bio Secures Permanent J-Code (J1738) for ANJESO   GlobeNewswire Inc
Jul 20, 2020
07:02AM EDT  Baudax Bio Enters Pharmacy Supplier Agreement With Vizient Inc. for ANJESO   Benzinga
07:00AM EDT  Baudax Bio Secures Pharmacy Supplier Agreement with Vizient Inc.   GlobeNewswire Inc


Share
About
Symbol List

Pricing
Disclaimer

ChartExchange on Twitter
ChartExchange on Reddit
© 2020 - 2023 ChartExchange LLC